(Q54645843)

2 June 2018

title

Induction of cell death in human papillomavirus 18-positive cervical cancer cells by E6 siRNA. (English)

1 reference

2 June 2018

1 reference

cervix uterine cancer

1 reference

Yamato K

1

1 reference

2 June 2018

Fen J

2

1 reference

2 June 2018

Kobuchi H

3

1 reference

2 June 2018

Nasu Y

4

1 reference

2 June 2018

Yamada T

5

1 reference

2 June 2018

Nishihara T

6

1 reference

2 June 2018

Ikeda Y

7

1 reference

2 June 2018

Kizaki M

8

1 reference

2 June 2018

Yoshinouchi M

9

1 reference

2 June 2018

publication date

1 March 2006

1 reference

2 June 2018

published in

Cancer Gene Therapy

1 reference

2 June 2018

volume

13

1 reference

2 June 2018

page(s)

234-241

1 reference

2 June 2018

issue

3

1 reference

2 June 2018

https://scigraph.springernature.com/pub.10.1038/sj.cgt.7700891

exact match

0 references

cites work

Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700891

Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700891

Silencing of H-ras gene expression by retrovirus-mediated siRNA decreases transformation efficiency and tumorgrowth in a model of human ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700891

Selective silencing of viral gene expression in HPV-positive human cervical carcinoma cells treated with siRNA, a primer of RNA interference

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700891

In vitro and in vivo growth suppression of human papillomavirus 16-positive cervical cancer cells by e6 siRNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700891

The human papillomavirus E6 protein and its contribution to malignant progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700891

siRNA targeting of the viral E6 oncogene efficiently kills human papillomavirus-positive cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700891

RNA interference of human papillomavirus type 18 E6 and E7 induces senescence in HeLa cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700891

Cloning and expression of the cDNA for E6-AP, a protein that mediates the interaction of the human papillomavirus E6 oncoprotein with p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700891

Localization of the E6-AP regions that direct human papillomavirus E6 binding, association with p53, and ubiquitination of associated proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700891

Caspase 8 small interfering RNA prevents acute liver failure in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700891

Inhibition of hepatitis B virus in mice by RNA interference

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700891

Small interfering RNA Inhibits Hepatitis B virus replication in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700891

Interference of hepatitis C virus RNA replication by short interfering RNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700891

Suppression of hepatitis C virus replicon by RNA interference directed against the NS3 and NS5B regions of the viral genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700891

Sustained small interfering RNA-mediated human immunodeficiency virus type 1 inhibition in primary macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700891

Human papillomavirus-induced carcinogenesis and the ubiquitin-proteasome system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700891

Human papillomavirus types 16 E6 and E7 contribute differently to carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700891

The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700891

Human papillomavirus (HPV) E6 interactions with Bak are conserved amongst E6 proteins from high and low risk HPV types

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700891

Basal and human papillomavirus E6 oncoprotein-induced degradation of Myc proteins by the ubiquitin pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700891

Expression and splicing patterns of human papillomavirus type‐16 mrnas in pre‐cancerous lesions and carcinomas of the cervix, in human keratinocytes immortalized by HPV 16, and in cell lines established from cervical cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700891

Endogenous human papillomavirus E6 and E7 proteins differentially regulate proliferation, senescence, and apoptosis in HeLa cervical carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700891

Alternatively spliced HPV-18 E6* protein inhibits E6 mediated degradation of p53 and suppresses transformed cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700891

Molecular pathogenesis of cancer of the cervix and its causation by specific human papillomavirus types

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700891

7 January 2021

Interactions of human papillomavirus transforming proteins with the products of tumor suppressor genes.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700891

7 January 2021

Dissociation of bone morphogenetic protein-mediated growth arrest and apoptosis of mouse B cells by HPV-16 E6/E7

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700891

7 January 2021

RNA interference targeting Fas protects mice from fulminant hepatitis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700891

7 January 2021

Gene silencing by systemic delivery of synthetic siRNAs in adult mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700891

7 January 2021

siRNA-directed inhibition of HIV-1 infection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700891

7 January 2021

Oncogenic and nononcogenic human genital papillomaviruses generate the E7 mRNA by different mechanisms

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700891

7 January 2021

Identifiers

DOI

10.1038/SJ.CGT.7700891

1 reference

2 June 2018

PubMed ID

16138119

1 reference

2 June 2018